PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.245
-0.045 (-3.49%)
At close: May 18, 2026, 4:00 PM EDT
1.250
+0.005 (0.40%)
After-hours: May 18, 2026, 4:10 PM EDT
PMV Pharmaceuticals Employees
PMV Pharmaceuticals had 54 employees as of December 31, 2025. The number of employees increased by 7 or 14.89% compared to the previous year.
Employees
54
Change (1Y)
7
Growth (1Y)
14.89%
Revenue / Employee
n/a
Profits / Employee
-$1,450,815
Market Cap
66.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 54 | 7 | 14.89% |
| Dec 31, 2024 | 47 | -16 | -25.40% |
| Dec 31, 2023 | 63 | 1 | 1.61% |
| Dec 31, 2022 | 62 | 8 | 14.81% |
| Dec 31, 2021 | 54 | 10 | 22.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| XBiotech | 85 |
| Seres Therapeutics | 66 |
| Pliant Therapeutics | 49 |
| Cue Biopharma | 29 |
| PDS Biotechnology | 24 |
| Gain Therapeutics | 21 |
| ImageneBio | 15 |
| Actuate Therapeutics | 12 |
PMVP News
- 5 days ago - PMV Pharmaceuticals price target lowered to $5 from $6 at Oppenheimer - TheFly
- 6 days ago - PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c) - TheFly
- 26 days ago - PMV Pharmaceuticals chair Rich Heyman to depart, Laurie Stelzer to succeed - TheFly
- 26 days ago - PMV Pharmaceuticals Announces Board Chair Transition - GlobeNewsWire
- 5 weeks ago - PMV Pharmaceuticals price target lowered to $4 from $16 at Evercore ISI - TheFly
- 2 months ago - PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51) - TheFly
- 2 months ago - PMV Pharmaceuticals sees cash runway to end of 2Q27 - TheFly
- 2 months ago - PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights - GlobeNewsWire